Ross Clark

Ross Clark

Ross Clark is a leader writer and columnist who has written for The Spectator for three decades. He writes on Substack, at Ross on Why?

Every part of England would pass Germany’s Covid test

From our UK edition

As much as the government has any kind of strategy for lifting Britain out of lockdown it appears to revolve around the ‘R’ – or Reproduction – number. So long as this stays below one, we are told, the epidemic cannot progress – while the moment it strays above one then the disease will start

Are young people more likely to catch Covid?

From our UK edition

It has been clear from the outset of the Covid-19 pandemic that there is a very steep age profile to its victims: with few children and teenagers experiencing serious symptoms while their grandparents suffer a high death toll. But what about the numbers of people infected? Two studies, in Britain and Sweden, appear to show

Should Britain relax the two-metre distance rule?

From our UK edition

Could the Government be about to relax the two-metre rule for social distancing? On Wednesday morning, professor Robert Dingwall, a sociologist who sits on the New and Emerging Respiratory Virus Threats Advisory Group, questioned the rule, saying he had tried to trace the scientific justification for it but couldn’t. The evidence, he said, was ‘fragile’.

Stanford study suggests coronavirus might not be as deadly as flu

From our UK edition

One of the great unknowns of the Covid-19 crisis is just how deadly the disease is. Much of the panic dates from the moment, in early March, when the World Health Organisation (WHO) published a mortality rate of 3.2 per cent – which turned out to be a crude ‘case fatality rate’ dividing the number

Moderna’s vaccine breakthrough reveals the folly of UK efforts

From our UK edition

The effect that a commercially-available vaccine would have on the global economy was amply demonstrated on Monday afternoon. The FTSE 100 jumped by more than 4 per cent after an announcement from US drug company Moderna that results of phase one vaccine trials had been successful. Development of a vaccine has become an international race

Will a vaccine really be ready by September?

From our UK edition

Aside from a handful of anti-vaxxers, virtually everyone would leap at the prospect of a vaccine earning us an early exit from the Covid-19 crisis. The only snag is that we do not have a vaccine that is proven to work, let alone safe to use, and that it is improbable that we will have

Covid’s knock-on effect on child deaths

From our UK edition

The daily death toll has been a constant backdrop to the Covid-19 crisis. Would we ever have entered lockdown, would so many people have been driven to panic, were it not for the publication, every afternoon, of the number of deaths in the past 24 hours? It has helped set in the minds of the

Why are some people being repeatedly tested for coronavirus?

From our UK edition

Testing, the government keeps telling us, is the way out of the coronavirus lockdown. Soon, the Prime Minister assured us in his address to the nation last Sunday, we will be testing ‘literally hundreds of thousands of people every day’. Given that Matt Hancock seems finally to have achieved his ambition of testing 100,000 people

Could having a cold protect against Covid?

From our UK edition

Could having a common cold protect you against Covid-19? The intriguing prospect has been raised by a team from the La Jolla Institute for Immunology in California. They were researching the response of human T cells – which play a vital role in the immune system – in patients who have recovered from Covid-19. The

This study from Iceland suggests reopening schools is safe

From our UK edition

Some countries are refusing to open their schools for fear of a prompting a second wave of coronavirus infections. But their policies would appear to be flatly contradicted by evidence from Iceland. There, a company called deCODE Genetics, in association with the country’s directorate of health and the national university hospital, has analysed the results

Are we seeing 2000 excess deaths a week from non-coronavirus causes?

From our UK edition

Cambridge professor of the public understanding of risk David Spiegelhalter recently made the point that, given the uncertainties over exactly what constitutes a death from coronavirus, the number we should we watching is the ONS’s figure for deaths from all causes. That, he argued, will give us the surest indication as to the progress of

How do we know which lockdown measures should be lifted first?

From our UK edition

Today, the cabinet has to decide where to go next with the lockdown – although the decision will not be announced until Sunday. Boris Johnson has talked of a ‘menu of options’ for relaxing some of the measures, but we have been warned not to expect too much. The government has also distanced itself from

Israel’s antibody breakthrough

From our UK edition

The Israeli government is reporting this morning that the country’s Institute for Biological Research has made a breakthrough in the development of a potential treatment against SARS-CoV-2, the virus which causes Covid-19. Scientists there have isolated a ‘monoclonal neutralising antibody’ which could potentially neutralise the virus after infection. The antibody was obtained from the blood

Herd immunity may only need 10-20 per cent of people to be infected

From our UK edition

Since mid-March there has been an assumption that herd immunity against Covid-19 would not be achieved until around 60 per cent of the population has been infected. It is a figure which gave rise to the now-famous paper by Professor Neil Ferguson of Imperial College, which claimed that a herd immunity policy (which the government

Have we been fighting a very different disease to China?

From our UK edition

One of the great mysteries of coronavirus is how the epidemic has become much more severe in Europe and North America than in the Far East. A disease which appeared to be on the wane in China, South Korea and elsewhere in mid-February suddenly erupted with a vengeance in Europe in March, with death tolls

Coronavirus reinfection fears appear to be unfounded

From our UK edition

A week ago, the World Health Organisation (WHO) issued a warning which, if it were true, would constitute the most depressing-yet development in the story of Covid-19. It said that there was ‘no evidence’ that people who have already been infected with the disease, and who have developed antibodies as a result, have gained any

Could Remdesivir eliminate the need for a coronavirus vaccine?

From our UK edition

Over the past few weeks the government’s scientific advisers have indicated that the only real way out of the coronavirus crisis is a vaccine – until then a high degree of social distancing will have to remain. Given that no-one expects a vaccine to be ready for deployment for another year at the very earliest,

How New Zealand won its fight with coronavirus

From our UK edition

A milestone was reached today when New Zealand became the first country to declare that all community transmission of coronavirus has effectively ceased. We have previously seen China (whose figures are not universally trusted), South Korea and Vietnam wrestle their figures for new cases of the disease down to very low levels, but New Zealand’s

Britain can’t rely on a vaccine to ease lockdown restrictions

From our UK edition

Six weeks ago Britain stood as a bit of an outlier among western countries in that our government seemed set to manage, rather than suppress, coronavirus. It rejected the idea that it was pursuing ‘herd immunity,’ but seemed to do just that. Now we stand out for a different reason: we are the only country

Could this antibody test offer a route out of lockdown?

From our UK edition

Finally, the government is to start antibody tests to see how prevalent infection with the SARS-CoV-2 virus – which causes Covid-19 – is among the general population. Over the next few days, testing kits are being sent to 20,000 randomly-selected households. The results will be crucial because it will inform us how effective lockdown has